Alcohol-related Liver Disease Clinical Trials

17 clinical trials for Alcohol-related Liver Disease across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease — RECRUITING · NA
• CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome — RECRUITING
• Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients — RECRUITING · NA
• Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease — RECRUITING
• Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation — RECRUITING
• Peer Support for Liver Transplant Recipients With History of ALD — NOT_YET_RECRUITING · NA
• Clinical Characteristics of Recompensation — ACTIVE_NOT_RECRUITING
• Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease — COMPLETED · PHASE2
• Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease — OTHER · PHASE2
• A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests — NOT_YET_RECRUITING
• Genetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis. — NOT_YET_RECRUITING
• Investigating Myosteatosis in Steatotic Liver Diseases — OTHER
• Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden. — OTHER · NA
• Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease — OTHER · NA
• Alcohol Biomarkers in Post-Liver Transplant Patients — COMPLETED
• Acamprosate Safe to Use in Individuals With Liver Disease. — COMPLETED · PHASE2
• Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) — OTHER

Refine this search